What is HC Wainwright’s Forecast for Transcat Q4 Earnings?

Transcat, Inc. (NASDAQ:TRNS) – Research analysts at HC Wainwright issued their Q4 2026 earnings per share estimates for shares of Transcat in a report issued on Wednesday, May 21st. HC Wainwright analyst S. Buck forecasts that the scientific and technical instruments company will post earnings per share of $0.70 for the quarter. HC Wainwright currently has a “Buy” rating and a $116.00 target price on the stock. The consensus estimate for Transcat’s current full-year earnings is $2.30 per share.

TRNS has been the subject of several other reports. Oppenheimer lowered Transcat from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 29th. Northland Securities reissued a “market perform” rating and issued a $85.00 price objective (down previously from $110.00) on shares of Transcat in a report on Wednesday, January 29th. Finally, Wall Street Zen raised Transcat from a “sell” rating to a “hold” rating in a report on Tuesday. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $114.00.

Transcat Trading Up 1.4%

Shares of Transcat stock opened at $91.63 on Thursday. Transcat has a 1 year low of $67.56 and a 1 year high of $147.12. The firm has a market cap of $852.98 million, a PE ratio of 49.53 and a beta of 0.69. The stock has a fifty day moving average price of $79.06 and a 200-day moving average price of $89.79. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.42 and a quick ratio of 1.98.

Transcat (NASDAQ:TRNS) last announced its earnings results on Monday, May 19th. The scientific and technical instruments company reported $0.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.66 by ($0.02). Transcat had a net margin of 6.22% and a return on equity of 7.23%. The business had revenue of $77.13 million for the quarter, compared to analysts’ expectations of $76.40 million. The firm’s revenue was up 8.8% on a year-over-year basis.

Institutional Investors Weigh In On Transcat

Several large investors have recently added to or reduced their stakes in TRNS. Barclays PLC increased its holdings in Transcat by 393.0% in the 3rd quarter. Barclays PLC now owns 15,130 shares of the scientific and technical instruments company’s stock worth $1,826,000 after acquiring an additional 12,061 shares during the last quarter. SG Americas Securities LLC purchased a new stake in Transcat in the 4th quarter worth about $182,000. Linden Thomas Advisory Services LLC increased its holdings in Transcat by 23.2% in the 4th quarter. Linden Thomas Advisory Services LLC now owns 6,477 shares of the scientific and technical instruments company’s stock worth $685,000 after acquiring an additional 1,219 shares during the last quarter. Catawba River Capital increased its holdings in Transcat by 2.2% in the 4th quarter. Catawba River Capital now owns 67,300 shares of the scientific and technical instruments company’s stock worth $7,116,000 after acquiring an additional 1,473 shares during the last quarter. Finally, Rhumbline Advisers boosted its stake in Transcat by 4.1% in the 4th quarter. Rhumbline Advisers now owns 12,348 shares of the scientific and technical instruments company’s stock worth $1,306,000 after purchasing an additional 486 shares during the period. Hedge funds and other institutional investors own 98.34% of the company’s stock.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.